Boiron logo

Boiron

Canada-wide class action alleges Boiron misled consumers by advertising Oscillo as a flu cure despite it being a sugar placebo.

Opening soonCanada-wideClaim deadline: Pending court decisionEstimated payout: Compensation pendingClaims not open yet

About this settlement

The lawsuit alleges that Oscillo was falsely advertised as an effective flu treatment when it contains no active medicinal ingredients.

This class action challenges Boiron's advertising of Oscillococcinum as a flu cure, asserting it is a sugar placebo with no active ingredients or health benefits. The case is certified by the Quebec Court of Appeal and covers all Canadian residents who purchased Oscillo products.

Who qualifies

  • Residents of Canada who purchased Oscillococcinum or Children Oscillococcinum.
  • Individuals misled by the product's advertising claims.

Compensation pending

Claim deadline: Pending court decision

Related settlements

Estée Lauder logo

Estée Lauder

No proof required

Up to $5,000

Claims opening soon

Silk and Great Value logo

Silk and Great Value

Proof required

Up to $300,000

99 days left

Audible logo

Audible

No proof required

Compensation pending

Claims opening soon

Government of Canada logo

Government of Canada

Proof required

Up to $200,000

749 days left

Meta (Facebook) logo

Meta (Facebook)

No proof required

Up to $90

Claims opening soon

Ticketmaster logo

Ticketmaster

No proof required

Compensation pending

Claims opening soon